🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The DAPA-HF trial demonstrated that dapagliflozin was able to reduce the ri...
Status
Completed
Location
Cheng Hsin General Hospital
Start Date
2020-05-29
Trial ID
NCT04575675
BACKGROUND Beta-blockers improve left ventricular (LV) systolic function an...
Status
Terminated
Location
IRCCS San Raffaele
Start Date
2004-01
Trial ID
NCT00511888
The purpose of this study was to compare the tolerability of nebivolol to m...
Status
Terminated
Location
Forest Research Institute 014
Start Date
2007-10-31
Trial ID
NCT00547300
Treatments Being Tested
As the cancer-related prognosis improves thanks to recent advances in cance...
Status
Unknown
Location
IRCCS Humanitas Research Hospital
Start Date
2019-01-01
Trial ID
NCT05728632
The objective is to determine whether nebivolol, a beta-blockade drug, can ...
Status
Completed
Location
Armand Trousseau Hospital
Start Date
2012-02-13
Trial ID
NCT01648634
The study was conducted to determine the long-term safety and efficacy of n...
Status
Completed
Location
Mylan Pharmaceuticals Inc.
Start Date
2002-03
Trial ID
NCT00200499
Treatments Being Tested
High blood pressure (hypertension) is called the "silent killer" because ma...
Status
Completed
Location
Emory University
Start Date
2009-12
Trial ID
NCT01049009
Treatments Being Tested
The purpose of this study is to directly compare the blood pressure (hypert...
Status
Withdrawn
Location
University of Mississippi Medical Center
Start Date
2010-02
Trial ID
NCT01076140
Treatments Being Tested
The purpose of this study is to demonstrate the safety and effectiveness of...
Status
Withdrawn
Location
University of Chicago Medical Center
Start Date
2012-01
Trial ID
NCT01939990
The HYIMPACT study (IMPACT of Nebilet® in Blood Pressure Control in Patient...
Status
Recruiting
Location
Telogorejo Hospital
Start Date
2023-12-20
Trial ID
NCT06938516